COMMUNIQUÉS West-GlobeNewswire

Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
13/05/2026
- Composition of matter provisional patent application filed for a new form of brilaroxazine designed to extend patent life and commercial exclusivity through 2046 - - FDA feedback on use of new form of brilaroxazine in [...]
LogicMark, Inc. Announces Strong First Quarter 2026 Results
13/05/2026
Revenue Up 24% as Gross Margin Expands to 69.6% and Operating Loss Narrows LOUISVILLE, Ky., May 13, 2026 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK) (the “Company”), a provider of personal safety and emergency [...]
aTyr Pharma to Participate in Upcoming Investor Conferences
13/05/2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA [...]
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
13/05/2026
First clinical data from PRMT5/RAS(ON) combination trial to be pre sented in 2026 Cash position of $380 million as of March 31, 2026, with runway into 2028 beyond anticipated key data inflection points BOSTON, May 13, [...]
Bionano Reports First Quarter 2026 Results and Provides a Business Update
13/05/2026
Conference call today, May 13, 2026, at 4:30 PM ET SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The [...]
Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results
13/05/2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc. (NASDAQ: BLTE), (“Belite Bio®” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics [...]
Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
13/05/2026
Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026 Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union, and the United [...]
Management team’s 2025 market-based Options have vested
13/05/2026
Share price increase from $6 to $30 triggers full vesting NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that 2025 employee stock options [...]
Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
13/05/2026
New Drug Application (NDA) for tebipenem HBr for complicated urinary tract infections (cUTI), including pyelonephritis, is under review at the FDA, with PDUFA date of June 18, 2026 Spero maintains its cash runway [...]
Hard Chews Gummies Claims Evaluated: Investigating the Salt Tonic Trick Recipe for Men
14/05/2026
Hard Chews Gummies Ingredients, Male Performance Support, L-Arginine, Tongkat Ali, Maca Root, 180-Day Guarantee, Pricing, and Subscribe and Save Researched Aurora, CO, May 13, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
13/05/2026
ORKA-001 EVERLAST-A 16-week data showed 63.5% PASI 100 rate and a favorable tolerability profile, with longer-term data expected in 2H 2026 ORCA-SURGE Phase 2 trial of ORKA-002 in psoriasis initiated with data expected [...]
Assemblée Générale Mixte du 3 juin 2026
13/05/2026
Châtillon, France, le 13 mai 2026 Assemblée Générale Mixte du 3 juin 2026 Modalités de mise à disposition des informations et documents préparatoires à l’Assemblée Générale Mixte DBV Technologies (Euronext : DBV – ISIN [...]
Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress
13/05/2026
Received initial purchase orders for recombinant bovine transferrin from customers in the cultivated meat industry Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using [...]
Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results
13/05/2026
Conference Call Scheduled for today, May 13, 2026, at 5:00pm ET LITTLETON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced [...]
MAPS Announces Dates for Psychedelic Science 2027; Early Bird Registrations Now Open
13/05/2026
Early bird registration is now open for Psychedelic Science 2027, taking place May 3–7, 2027, in Denver, Colorado. Early bird pricing offers discounted registration in limited quantities to the world’s leading [...]
Berry Street Partners with Factor, Bringing Personalized Nutrition Therapy to Leading Meal Delivery Service
13/05/2026
Factor’s expansive customer base can now work with expert Registered Dietitians who see their actual meal choices, turning every session into targeted recommendations NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- Berry [...]
Comprehensive Healthcare Names New COO and CHRO to Strengthen Growing Organization
13/05/2026
YAKIMA, Wash., May 13, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare, the leading community behavioral health provider in central and southwest Washington, today announced a promotion and an addition to its [...]
JavaTide Claims Evaluated: Investigating the Java Tide Ingredients for Purity and Potency
13/05/2026
JavaTide Prebiotic and Probiotic Weight Loss Support: Chicory Root Inulin, Resistant Starch, and Akkermansia muciniphila for Gut Health and Metabolism Explained Largo, FL, May 13, 2026 (GLOBE NEWSWIRE) -- These [...]
Chengdu Origen and Vanotech Announce KHN921 Investigational New Drug application clearance by the US FDA for the treatment of hypertrophic cardiomyopathy (HCM) associated with MYBPC3 mutations
13/05/2026
Investigational New Drug application for KHN921 received “study may proceed” from the US FDA. KHN921 is a potential "first-in-class" cardiovascular AAV gene therapy being developed for the treatment of hypertrophic [...]

Pages